U.S. markets closed

Avantor, Inc. (AVTR)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
27.32+0.44 (+1.64%)
At close: 4:00PM EST

26.80 -0.52 (-1.90%)
After hours: 5:54PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close26.88
Open27.16
Bid26.01 x 800
Ask29.49 x 800
Day's Range26.14 - 27.38
52 Week Range6.66 - 31.05
Volume5,709,143
Avg. Volume4,629,296
Market Cap15.867B
Beta (5Y Monthly)N/A
PE Ratio (TTM)303.56
EPS (TTM)0.09
Earnings DateApr 27, 2021 - May 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est33.52
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-43% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Barrons.com

    Bausch Health and Landos Biopharma See Activist Action

    Icahn Capital reached a pact to appoint Bausch Health directors. Perceptive Advisors disclosed a large stake in Landos Biopharma.

  • Moody's

    Avantor Funding, Inc. -- Moody's announces completion of a periodic review of ratings of Avantor Funding, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Avantor Funding, Inc.Global Credit Research - 23 Feb 2021New York, February 23, 2021 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Avantor Funding, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review discussion held on 23 February 2021 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • Avantor® to Participate at the Raymond James 42nd Annual Institutional Investor Conference
    PR Newswire

    Avantor® to Participate at the Raymond James 42nd Annual Institutional Investor Conference

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Raymond James 42nd Annual Institutional Investor Conference on Monday, March 1, 2021. Michael Stubblefield, President and CEO at Avantor, will represent Avantor in the segment beginning at approximately 4:40 p.m. Eastern Time.